Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,321 to 1,340 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic insights into biological mechanisms governing human ovarian ageing. | Nature | 2021 | 34349265 | PubTator, text mining | PubMed |
| Stress-related emotional and behavioural impact following the first COVID-19 outbreak peak. | Mol Psychiatry | 2021 | 34349224 | PubTator, text mining | PubMed |
| Evaluating effects of sex and age on white matter microstructural alterations in alcohol use disorder: A diffusion tensor imaging study. | Alcohol Clin Exp Res | 2021 | 34342014 | PubTator, text mining | PubMed |
| Lipid- and Polymer-Based Nanoparticle Systems for the Delivery of CRISPR/Cas9. | J Drug Deliv Sci Technol | 2021 | 34335878 | PubTator, text mining | PubMed |
| High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals. | Front Immunol | 2021 | 34335605 | PubTator, text mining | PubMed |
| Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study. | Front Immunol | 2021 | 34335560 | PubTator, text mining | PubMed |
| Diagnostic difficulties and possibilities of NF1-like syndromes in childhood. | BMC Pediatr | 2021 | 34325699 | PubTator, text mining | PubMed |
| Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer. | HGG Adv | 2021 | 34317694 | PubTator, text mining | PubMed |
| A study of elective genome sequencing and pharmacogenetic testing in an unselected population. | Mol Genet Genomic Med | 2021 | 34313030 | PubTator, text mining | PubMed |
| Development of the PARP inhibitor talazoparib for the treatment of advanced BRCA1 and BRCA2 mutated breast cancer. | Expert Opin Pharmacother | 2021 | 34309473 | PubTator, text mining | PubMed |
| Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. | Nat Cancer | 2021 | 34308366 | PubTator, text mining | PubMed |
| The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma. | Front Oncol | 2021 | 34307148 | PubTator, text mining | PubMed |
| Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival. | Nat Commun | 2021 | 34301934 | PubTator, text mining | PubMed |
| Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target. | Cancers (Basel) | 2021 | 34298653 | PubTator, text mining | PubMed |
| m6A mRNA Methylation Regulates Epithelial Innate Antimicrobial Defense Against Cryptosporidial Infection. | Front Immunol | 2021 | 34295340 | PubTator, text mining | PubMed |
| Feel-Good Requirements: Neurophysiological and Psychological Design Criteria of Affective Touch for (Assistive) Robots. | Front Neurorobot | 2021 | 34295234 | PubTator, text mining | PubMed |
| Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers. | Sci Rep | 2021 | 34285288 | PubTator, text mining | PubMed |
| Molecular profiling of basal cell carcinomas in young patients. | BMC Med Genomics | 2021 | 34284772 | PubTator, text mining | PubMed |
| Clinically Advanced Pheochromocytomas and Paragangliomas: A Comprehensive Genomic Profiling Study. | Cancers (Basel) | 2021 | 34282751 | PubTator, text mining | PubMed |
| Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors. | Adv Ther | 2021 | 34282527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=67